Selected research
Industry Growth & Trends
Global Oncolytic Virus Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Oncolytic Virus Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Oncolytic Virus Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Oncolytic Virus Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Oncolytic Virus Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Oncolytic Virus Service market include Creative Biolabs, Creative Biogene, Recipharm, Nabios, IDT Biologika, FUJIFILM Diosynth Biotechnologies, Exothera, Lonza and ABL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Oncolytic Virus Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Oncolytic Virus Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oncolytic Virus Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oncolytic Virus Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Oncolytic Virus Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Oncolytic Virus Service Market by Company
Creative Biolabs
Creative Biogene
Recipharm
Nabios
IDT Biologika
FUJIFILM Diosynth Biotechnologies
Exothera
Lonza
ABL
Takara Bio
Libentech
Oncolytic Virus Service Segment by Type
Measles Virus (MeV)
Herpes Simplex Virus (HSV-1)
Others
Oncolytic Virus Service Segment by Application
Tumor Treatment
Scientific Research
Oncolytic Virus Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncolytic Virus Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oncolytic Virus Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncolytic Virus Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Oncolytic Virus Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Measles Virus (MeV)
- Herpes Simplex Virus (HSV-1)
- Others
Applications
- Tumor Treatment
- Scientific Research
Companies covered
- Creative Biolabs
- Creative Biogene
- Recipharm
- Nabios
- IDT Biologika
- FUJIFILM Diosynth Biotechnologies
- Exothera
- Lonza
- ABL
- Takara Bio
- Libentech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Oncolytic Virus Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Oncolytic Virus Service Market Size by Region (2021-2032)
- 1.4.1 Global Oncolytic Virus Service Market Size by Region (2021-2026)
- 1.4.2 Global Oncolytic Virus Service Market Size by Region (2027-2032)
- 1.5 Key Regions Oncolytic Virus Service Market Size (2021-2032)
- 1.5.1 North America Oncolytic Virus Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Oncolytic Virus Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Oncolytic Virus Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Oncolytic Virus Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Oncolytic Virus Service Market Size Growth Rate (2021-2032)
2 Oncolytic Virus Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Measles Virus (MeV)
- 2.1.2 Herpes Simplex Virus (HSV-1)
- 2.1.3 Others
- 2.2 Global Oncolytic Virus Service Market Size by Type
- 2.2.1 Global Oncolytic Virus Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Oncolytic Virus Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Oncolytic Virus Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Oncolytic Virus Service Market Size by Regions
- 2.3.1 North America Oncolytic Virus Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Oncolytic Virus Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Oncolytic Virus Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Oncolytic Virus Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Oncolytic Virus Service Market Size Breakdown by Type (2021-2026)
3 Oncolytic Virus Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Tumor Treatment
- 3.1.2 Scientific Research
- 3.2 Global Oncolytic Virus Service Market Size by Application
- 3.2.1 Global Oncolytic Virus Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Oncolytic Virus Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Oncolytic Virus Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Oncolytic Virus Service Market Size by Regions
- 3.3.1 North America Oncolytic Virus Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Oncolytic Virus Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Oncolytic Virus Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Oncolytic Virus Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Oncolytic Virus Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Oncolytic Virus Service Industry Trends
- 4.2 Oncolytic Virus Service Industry Drivers
- 4.3 Oncolytic Virus Service Industry Opportunities and Challenges
- 4.4 Oncolytic Virus Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Oncolytic Virus Service Revenue (2021-2026)
- 5.2 Global Oncolytic Virus Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Oncolytic Virus Service Key Company Headquarters & Area Served
- 5.4 Global Oncolytic Virus Service Company, Product Type & Application
- 5.5 Global Oncolytic Virus Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Oncolytic Virus Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Oncolytic Virus Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Oncolytic Virus Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Creative Biolabs
- 6.1.1 Creative Biolabs Company Information
- 6.1.2 Creative Biolabs Business Overview
- 6.1.3 Creative Biolabs Oncolytic Virus Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Creative Biolabs Oncolytic Virus Service Product Portfolio
- 6.1.5 Creative Biolabs Recent Developments
- 6.2 Creative Biogene
- 6.2.1 Creative Biogene Company Information
- 6.2.2 Creative Biogene Business Overview
- 6.2.3 Creative Biogene Oncolytic Virus Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Creative Biogene Oncolytic Virus Service Product Portfolio
- 6.2.5 Creative Biogene Recent Developments
- 6.3 Recipharm
- 6.3.1 Recipharm Company Information
- 6.3.2 Recipharm Business Overview
- 6.3.3 Recipharm Oncolytic Virus Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Recipharm Oncolytic Virus Service Product Portfolio
- 6.3.5 Recipharm Recent Developments
- 6.4 Nabios
- 6.4.1 Nabios Company Information
- 6.4.2 Nabios Business Overview
- 6.4.3 Nabios Oncolytic Virus Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Nabios Oncolytic Virus Service Product Portfolio
- 6.4.5 Nabios Recent Developments
- 6.5 IDT Biologika
- 6.5.1 IDT Biologika Company Information
- 6.5.2 IDT Biologika Business Overview
- 6.5.3 IDT Biologika Oncolytic Virus Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 IDT Biologika Oncolytic Virus Service Product Portfolio
- 6.5.5 IDT Biologika Recent Developments
- 6.6 FUJIFILM Diosynth Biotechnologies
- 6.6.1 FUJIFILM Diosynth Biotechnologies Company Information
- 6.6.2 FUJIFILM Diosynth Biotechnologies Business Overview
- 6.6.3 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Product Portfolio
- 6.6.5 FUJIFILM Diosynth Biotechnologies Recent Developments
- 6.7 Exothera
- 6.7.1 Exothera Company Information
- 6.7.2 Exothera Business Overview
- 6.7.3 Exothera Oncolytic Virus Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Exothera Oncolytic Virus Service Product Portfolio
- 6.7.5 Exothera Recent Developments
- 6.8 Lonza
- 6.8.1 Lonza Company Information
- 6.8.2 Lonza Business Overview
- 6.8.3 Lonza Oncolytic Virus Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Lonza Oncolytic Virus Service Product Portfolio
- 6.8.5 Lonza Recent Developments
- 6.9 ABL
- 6.9.1 ABL Company Information
- 6.9.2 ABL Business Overview
- 6.9.3 ABL Oncolytic Virus Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 ABL Oncolytic Virus Service Product Portfolio
- 6.9.5 ABL Recent Developments
- 6.10 Takara Bio
- 6.10.1 Takara Bio Company Information
- 6.10.2 Takara Bio Business Overview
- 6.10.3 Takara Bio Oncolytic Virus Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Takara Bio Oncolytic Virus Service Product Portfolio
- 6.10.5 Takara Bio Recent Developments
- 6.11 Libentech
- 6.11.1 Libentech Company Information
- 6.11.2 Libentech Business Overview
- 6.11.3 Libentech Oncolytic Virus Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Libentech Oncolytic Virus Service Product Portfolio
- 6.11.5 Libentech Recent Developments
7 North America
- 7.1 North America Oncolytic Virus Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Oncolytic Virus Service Market Size by Country (2021-2026)
- 7.3 North America Oncolytic Virus Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Oncolytic Virus Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Oncolytic Virus Service Market Size by Country (2021-2026)
- 8.3 Europe Oncolytic Virus Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Oncolytic Virus Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Oncolytic Virus Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Oncolytic Virus Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Oncolytic Virus Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Oncolytic Virus Service Market Size by Country (2021-2026)
- 10.3 South America Oncolytic Virus Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Oncolytic Virus Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Oncolytic Virus Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Oncolytic Virus Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst